Sancuso, ProStrakan’s innovative skin patch for the prevention of chemotherapy-induced nausea and vomiting (CINV), was launched in the US a year ago and revenues for the first 10 months of this year totalled £6.1m, the group said.
- Text size
ProStrakan in fine health and sets sights on US market
ProStrakan, Scotland’s rising pharmaceutical star, yesterday reported strong broad-based sales growth in its “breakthrough to profit” year of 2009, but said it was taking action to accelerate progress in a key product in the US.
